Download presentation
Presentation is loading. Please wait.
Published byIlker Berk Uysal Modified over 6 years ago
1
Thrombin activatable fibrinolysis inhibitor in Behçet's disease
Ayhan Donmez, Kenan Aksu, Handan Ak Celik, Gokhan Keser, Seckin Cagirgan, Serdar Bedii Omay, Vedat Inal, Hikmet Hakan Aydin, Murat Tombuloglu, Eker Doganavsargil Thrombosis Research Volume 115, Issue 4, Pages (January 2005) DOI: /j.thromres Copyright © 2004 Elsevier Ltd Terms and Conditions
2
Figure 1 TAFI plasma levels (mean±S.E.M.) for control, thrombosis (+), thrombosis (−) and total BD. All groups significant differences vs. control subjects (P<0.001). Thrombosis Research , DOI: ( /j.thromres ) Copyright © 2004 Elsevier Ltd Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.